비만 약물치료의 최신 경향
The prevalence of obesity with various complications is increasing rapidly in Korea. Although lifestyle modification is fundamental in obesity treatment, more effective treatment tools are required. Many advances in obesity treatment have been reported recently, including lifestyle modifications and...
Saved in:
| Published in | The Korean journal of gastroenterology Vol. 83; no. 3; pp. 94 - 101 |
|---|---|
| Main Authors | , |
| Format | Journal Article |
| Language | Korean |
| Published |
대한소화기학회
31.03.2024
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Summary: | The prevalence of obesity with various complications is increasing rapidly in Korea. Although lifestyle modification is fundamental in obesity treatment, more effective treatment tools are required. Many advances in obesity treatment have been reported recently, including lifestyle modifications and pharmacological, endoscopic, and surgical treatments. Drugs with proven long-term efficacy and safety are preferred because management for obesity treatment is a long-term process. Currently, four medications are available for long-term use in Korea: Orlistat, Naltrexone/bupuropion NR, Phentermine/topiramate capsule, and Liraglutide. Recently, semaglutide and tirzepatide have been attracting attention because of their effectiveness and convenience, but they are not yet available in Korea. In addition, there are limitations such as the yo-yo effect when discontinuing the drug, long-term safety, and cost. Patients and medical staff must be aware of the advantages and side effects of each medication to ensure the successful treatment of obesity. (Korean J Gastroenterol 2024;83:94-101) |
|---|---|
| Bibliography: | Korean Society of Gastroenterology |
| ISSN: | 1598-9992 |